Matsui Yu, Shimizu Tadamichi
Department of Dermatology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
Photodermatol Photoimmunol Photomed. 2025 Sep;41(5):e70046. doi: 10.1111/phpp.70046.
BACKGROUND/PURPOSE: Ultraviolet (UV) radiation is a key environmental carcinogen implicated in the development of various skin malignancies. Recent studies highlight the pivotal roles of macrophage migration inhibitory factor (MIF) and its homolog D-dopachrome tautomerase (DDT) in UV-induced skin carcinogenesis. This review aims to consolidate current knowledge of how MIF and DDT contribute to tumor initiation and progression under UV stress, with a focus on their biological functions, signaling pathways, and therapeutic potential.
This narrative review synthesizes findings from basic, translational, and clinical studies examining MIF and DDT in the context of UV-mediated skin carcinogenesis. The literature was selectively reviewed to highlight mechanistic insights, pathological significance, and emerging therapeutic strategies.
Both MIF and DDT are upregulated upon UVB exposure and promote tumorigenesis by suppressing p53-mediated apoptosis, enhancing inflammatory signaling, and modulating the tumor immune microenvironment. Transgenic mouse models demonstrate that overexpression of either cytokine accelerates UVB-induced tumor formation, while inhibition reduces tumor burden. Although MIF and DDT share CD74-mediated pathways, they exhibit mechanistically distinct yet functionally complementary roles. In addition to melanoma, emerging evidence suggests involvement in non-melanoma skin cancers, particularly cutaneous squamous cell carcinoma (cSCC). Selective small-molecule inhibitors are under development, and expression profiles of MIF and DDT are being evaluated as biomarkers for prognosis and response to immunotherapy.
MIF and DDT are critical mediators of UV-induced skin carcinogenesis. Their overlapping yet non-redundant signaling properties and emerging clinical relevance suggest that targeting these cytokines may offer new opportunities for prevention, diagnosis, and treatment of UV-induced skin cancers.
背景/目的:紫外线(UV)辐射是一种关键的环境致癌物,与多种皮肤恶性肿瘤的发生发展有关。最近的研究强调了巨噬细胞移动抑制因子(MIF)及其同源物D - 多巴色素互变异构酶(DDT)在紫外线诱导的皮肤癌发生中的关键作用。本综述旨在整合当前关于MIF和DDT在紫外线应激下如何促进肿瘤起始和进展的知识,重点关注它们的生物学功能、信号通路和治疗潜力。
本叙述性综述综合了基础、转化和临床研究的结果,这些研究在紫外线介导的皮肤癌发生背景下研究了MIF和DDT。对文献进行了选择性综述,以突出机制见解、病理意义和新兴治疗策略。
MIF和DDT在紫外线B(UVB)照射后均上调,并通过抑制p53介导的细胞凋亡、增强炎症信号和调节肿瘤免疫微环境来促进肿瘤发生。转基因小鼠模型表明,这两种细胞因子的过表达都会加速UVB诱导的肿瘤形成,而抑制则会减轻肿瘤负担。尽管MIF和DDT共享CD74介导的途径,但它们在机制上表现出不同但功能互补的作用。除黑色素瘤外,新出现的证据表明它们还参与非黑色素瘤皮肤癌,特别是皮肤鳞状细胞癌(cSCC)。选择性小分子抑制剂正在研发中,MIF和DDT的表达谱正在作为预后和免疫治疗反应的生物标志物进行评估。
MIF和DDT是紫外线诱导的皮肤癌发生的关键介质。它们重叠但非冗余的信号特性以及新出现的临床相关性表明,靶向这些细胞因子可能为紫外线诱导的皮肤癌的预防、诊断和治疗提供新的机会。